FAQs on Non-BCMA-Targeted Bispecific Antibodies in Multiple Myeloma

Want to learn more about bispecific antibodies? A myeloma care team sits down with Mary DeRome to answer frequently asked questions about the newest bispecific antibodies─a new and exciting option for treating myeloma.
Your feedback is important. Please click here to complete a brief survey: www.surveymonkey.com/r/W9MXHTN